Delivery Order SPE2DB22D2206-SPE2DB24FKA26

Award Date 8/27/24
Potential Completion Date 8/28/24
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg dose syringes. The contract has a ceiling value of $49,439.68 and a period of performance through May 6, 2025. It is a firm-fixed-price contract, indicating a pre-determined unit price for the medication. The contract is not set aside for any specific business type. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the specialty medication Cosentyx (Secukinumab) 300 mg dose. The contract has a ceiling value of $3,406.81 and an ultimate completion date of July 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg/2 mL injections. The contract has a ceiling value of $7,820.90 and a period of performance through May 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (Secukinumab) 300 mg/2 mL injectable medication. The contract has a ceiling value of $3,910.45 and a period of performance through July 1, 2025. It is a Firm Fixed Price contract, indicating a set price for the delivery of the specified medication. The contract is not set-aside and is open to all qualified vendors....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300mg doses. The $9,694.44 firm fixed price contract has an ultimate completion date of October 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range of medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx 300 mg injectable medication. The firm-fixed-price contract has a ceiling value of $13,982.82 and runs through November 23, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and covering a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the specialty medication Cosentyx (Secukinumab) 300 mg dose. The contract has a total ceiling value of $7,904.77 and a period of performance through August 2, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company. The contract is for the supply of Cosentyx (secukinumab) 300 mg doses in pre-filled syringes, with a total ceiling value of $10,049.44 and a completion date of February 10, 2025. The contract is a firm-fixed-price delivery order, and there was no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg injections. The contract has a ceiling value of $7,793.90 and an ultimate completion date of August 1, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cosentyx 300 mg doses in pre-filled syringes, with a ceiling value of $1,654.91 and a period of performance through May 25, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKA26
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg dosage syringes. The contract has a firm fixed price of $8,067.80 and a performance period that runs through August 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs. The contract does not have a set-aside designation.

Generated 11/26/24, 9:28 AM